Attenuated Mycobacterium tuberculosis vaccine protection in a low-dose murine challenge model
Summary: Bacillus Calmette–Guérin (BCG) remains the only approved tuberculosis (TB) vaccine despite limited efficacy. Preclinical studies of next-generation TB vaccines typically use a murine aerosol model with a supraphysiologic challenge dose. Here, we show that the protective efficacy of a live a...
Glavni autori: | , , , , , , , , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
Elsevier
2023-06-01
|
Serija: | iScience |
Teme: | |
Online pristup: | http://www.sciencedirect.com/science/article/pii/S2589004223010404 |